Table 2.
Main demographic and clinical features of the whole sample and subsets of patients (T0 = admission; T1 = median day of hospitalization; T2 = last day of hospitalization).
| TOTAL n = 764 |
SURVIVORS n = 534 |
ICU ADMITTED n = 106 |
DECEASED n = 124 |
p | |
|---|---|---|---|---|---|
| Age, Years | 74 (72–75) | 71 (69–73) | 71 (67–73) | 85 (84–86) | <0.000001 |
| Male Sex, n (%) | 412 (54.1) | 282 (68.2) | 69 (16.7) | 61 (14.8) | 0.019 |
| Lymph, 109/L | 800 (718–800) | 900 (800–900) | 581 (506–820) | 600 (500–671) | <0.000001 |
| ANC, 109/L | 6500 (6200–6800) | 5900 (5600–6300) | 7500 (6760–8927) | 9000 (7500–9039) | <0.000001 |
| P/F Ratio | 206 (198–224) | 258 (241–272) | 171(121–133) | 128 (117–146) | <0.000001 |
| NLR T0 | 8.18 (7.7–8.9) | 6.7 (6.2–7.3) | 13.2 (11.1–15.8) | 15.5 (13.6–18.6) | <0.000001 |
| NLR T1 | 8.7 (7.8–9.7) | 7 (6.1–7.8) | 13.5 (11–16) | 23 (17.8–31.3) | <0.000001 |
| NLR T2 | 8.9 (8.6–10.5) | 5.2 (4.5–5.3) | 13.5 (12.4–22.4) | 33 (22.6–41.7) | <0.000001 |
| CRP T0, mg/dL | 9.4 (8.4–10.6) | 7.7 (6.2–8.7) | 22 (12.8–73.8) | 13 (9.3–15.5) | <0.000001 |
| CRP T1, mg/dL | 3.3 (2.5–4.5) | 1.9 (1.4–2.4) | 16.2 (8.5–25) | 9.7 (6.9–11) | <0.000001 |
| CRP T2, mg/dL | 4.9 (3–6.6) | 1.5 (1.3–2.2) | 52.7 (22.4–101) | 10 (8.1–16.8) | <0.000001 |
| Length of Stay, Days | 9 (8–10) | 10 (10–11) | 4 (3–5) | 8 (7–9) | <0.000001 |
| Comorbidities | |||||
| Hypertension n (%) | 457 (62.5) | 306 (57) | 68 (64) | 83 (66) | 0.09 |
| Diabetes, n (%) | 334 (43.9) | 221 (41) | 47 (44) | 66 (53) | 0.06 |
| CKD, n (%) | 166 (21.7) | 105 (19) | 30 (28) | 31 (25) | 0.082 |
| COPD, n (%) | 107 (13.8) | 82 (15) | 11 (10) | 14 (11) | 0.252 |
| CV Disease, n (%) | 297 (25.7) | 198 (37) | 47 (44) | 52 (41) | 0.279 |